Intrexon Corporation

États‑Unis d’Amérique


 
Quantité totale PI 112
Quantité totale incluant filiales 164 (+ 52 pour les filiales)
Rang # Quantité totale PI 11 744
Note d'activité PI 1,1/5.0    3
Rang # Activité PI 343 476
Activité incl filiales 1,9/5.0    22
Symbole boursier XON (nasdaq)
ISIN US46122T1025
Capitalisation 756M  (USD)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

31 0
11 5
57 0
8
 
Dernier brevet 2021 - Lettuce with increased shelf life
Premier brevet 1996 - Production of heterologous peptides
Dernière marque 2018 - INTREXON BETTER DNA
Première marque 2009 - INTREXON

Filiales

5 subsidiaries with IP (12 patents, 40 trademarks)

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2020 Invention Lettuce with increased shelf life. The present application is directed to lettuce plants comprisi...
Invention Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone r...
Invention Vectors conditionally expressing therapeutic proteins, host cells comprising the vectors, and use...
2019 Invention Serine recombinases mediating stable integration into plant genomes. Described is a serine recomb...
Invention Crystalline diacylhydrazine and the use thereof. The present disclosure provides crystalline pol...
Invention Cells and methods for the production of ursodeoxycholic acid and precursors thereof. Genetically-...
Invention Boron-containing diacylhydrazines. The present disclosure provides boron-containing diacylhydrazi...
Invention Exosome delivery of skin care peptides. Skin care compositions comprising milk derived exosomes l...
Invention Ror-1 specific chimeric antigen receptors and uses thereof. Provided herein are chimeric antigen ...
Invention Fusion constructs and methods of using thereof. Provided herein is a composition comprising a fus...
Invention In vivo controlled combination therapy for treatment of cancer. Disclosed herein are improved met...
Invention Muc16 specific chimeric antigen receptors and uses thereof. Provided herein are chimeric antigen ...
Invention Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules...
Invention Tilapia with enhanced growth characteristics. The Invention provides Tilapia with enhanced growth...
Invention Hepatitis b vaccines and uses of the same. Provided herein are engineered hepatitis B virus (HBV)...
Invention Human papillomavirus vaccines and uses of the same. Provided herein are engineered human papillom...
2018 Invention Polypeptide compositions comprising spacers. Disclosed herein are methods and compositions includ...
Invention Advanced genome editing. Methods of genetically modifying microorganisms using advanced genome ed...
Invention Intercalated single-chain variable fragments. Single chain antibody polypeptides with engineered...
Invention Microorganisms and methods for the fermentation of cannabinoids. Disclosed herein are microorgani...
Invention Microorganisms and methods for the fermentation of cannabinoids. Disclosed herein are micro...
P/S Chemicals for use in biochemical and chemical industry; chemicals for use in agriculture, except ...
Invention Microorganisms and methods in the fermentation of benzylisoquinoline alkaloids. [00018] Disclosed...
Invention Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expr...
Invention Endoplasmic reticulum localization signals. The invention relates to cellular localization signa...
Invention Site-specific serine recombinases and methods of their use. Mycobacterium smegmatis phage recombi...
Invention Expression of novel cell tags. Disclosed herein are polynucleotides encoding cell tags for use in...
Invention Vectors conditionally expressing protein. This invention relates to the field of therapeutics. D...
Invention Engineered cells expressing multiple immunomodulators and uses thereof. This invention relates t...
Invention Methods and microorganisms for the fermentation of methane to multi-carbon compounds. Genetically...
Invention Delivery of autologous cells comprising matrix metalloproteinase for treatment of scleroderma. T...
Invention Delivery of autologous cells comprising matrix metalloproteinase for treatment of scleroderma. Th...
Invention Methods and microorganisms for making 1,4-butanediol and derivatives thereof from c1 carbons. Gen...
Invention Boron-containing diacylhydrazine compounds. The present disclosure provides boron-containing diac...
Invention Molecular switches. Genetically modified microorganisms that have the ability to convert carbon s...
Invention Methods and microorganisms for making 2,3-butanediol and derivatives thereof from c1 carbons. Gen...
Invention Modulating expression of polypeptides via new gene switch expression systems. Disclosed herein ar...
2017 Invention Steroid administration and immunotherapy. Disclosed herein include methods of inducing expansion ...
Invention Frataxin expression constructs. The invention provides polynucleotides, vectors and viruses expre...
P/S Chemicals, biochemicals and reagents for use in industry and science; chemicals, biochemicals and...
2016 Invention Improved therapeutic control of proteolytically sensitive, destabilized forms of interleukin-12. ...
P/S Chemicals, namely, chemicals for use in industry and science; chemicals for use in biochemical an...
Invention Ligand inducible polypeptide coupler system. The invention relates to a novel ligand inducible p...
2014 P/S Computer software for providing access to databases and information for use in connection with re...
P/S Clothing, namely, shirts, hats, and pajamas.
P/S Synthetic grass, namely, artificial turf. Technology transfer services, namely, licensing and tra...
2013 P/S Chemicals, biochemical and reagents for use in industry and science, namely, agricultural chemica...
P/S Laboratory apparatus for chemical and biochemical research and analysis, namely, in situ biologic...
2011 P/S Chemicals, namely, chemicals for use in industry and science, namely, for gene therapy, for treat...
P/S Chemicals and chemical reagents, namely ligands, genetic vectors, genetic hosts, genetic biochemi...
2009 P/S Technology transfer services, namely, licensing and transfer of intellectual property; developmen...